###### Strengths and limitations of this study

-   This is the first study to look at the use of wearable accelerometers to measure and characterise physical activity in high-risk elderly patients in the preoperative period.

-   We present a robust and objective method of measuring physical activity levels and compared this to self-reporting methods of measuring physical activity.

-   We were able to assess the impact of an existing unoptimised preoperative intervention using accelerometery.

-   Limitations of this study include small sample size although this is justified by the fact that it was an initial pilot study to establish normative physical activity and acceptability data to facilitate power calculations for further studies.

Introduction {#s1}
============

The 'high-risk' surgical population is characterised by advanced age, frailty and multiple comorbidities particularly when undergoing major surgery. This population accounts for just 12.5% of surgical procedures, but over 80% of perioperative deaths in the UK.[@R1] With an ageing population, increasing numbers of high-risk patients require surgery. It is therefore important to improve our understanding of risk factors for perioperative complications in order to facilitate shared decision-making and appropriate planning of perioperative care.

Frailty status is an independent predictor of postoperative morbidity and mortality[@R2] and physical inactivity is a defining feature of frailty. Older adults spend a significant part of their day being sedentary[@R4] and do not meet current physical activity (PA) recommendations.[@R5] Increased PA can slow progression to a frail state[@R7] and there is growing evidence for the positive association between preoperative PA and perioperative outcomes.[@R8] Prehabilitation programmes incorporate optimisation of medical, nutritional and psychological status alongside prescribed exercise training programmes with specific goals of muscle strengthening and increased physical fitness, but are labour intensive and most have suboptimal participant adherence rates.[@R9] PA may also be an attractive prehabilitation target although it is currently not known whether improving PA is feasible or leads to improvements in outcome.

Sustained changes in habitual, environmentally cued health behaviours are notoriously difficult to achieve,[@R10] but it is plausible that the preoperative period, due to the well-defined target endpoint (surgery), may represent a unique teachable moment during which motivation to convert intention into action may be elevated, and a sustained change in behaviour may be more achievable than other settings. Thus, it may be possible to influence patient behaviours in order to reduce perioperative risk and improve outcomes.

Since the high-risk surgical group is likely to differ from the general population, normative PA data and patient acceptability data are lacking and this needs to be established before targeted intervention studies can be designed. To this end, it is critical to first have a robust, precise method of measuring PA and to understand PA related to daily routine in order to establish a baseline against which the impact of future interventions could be measured. Traditionally, in the perioperative setting, patients' PA levels have been evaluated using brief self-report questionnaires; however, these are prone to error and recall bias.[@R11] The gold standard method of direct observation is labour intensive and time consuming, and therefore not feasible for widespread use.[@R12] Accelerometers could offer a potential solution; triaxial accelerometers detect magnitude and direction of acceleration and have been used in large-scale epidemiological studies to provide a valid estimate of overall PA.[@R13] They are unobtrusive and non-invasive and can measure PA in free-living environments and may offer a means to assess the efficacy and therefore optimise interventions to improve PA. However, this first requires the specific population of interest to be characterised. Although wrist-worn accelerometery has been validated to measure PA in older patients,[@R13] to our knowledge wearable accelerometers have not previously been used to characterise PA in a high-risk elderly population in the preoperative period. Furthermore, the acceptability of PA measurement has not been established in these patients.

Through this pilot study, we aimed to characterise PA levels in relation to daily routine across a variety of surgical specialties in order to obtain normative data to inform sample size calculations for future intervention studies. We also sought to assess whether there was a change in PA following current preoperative interventions (which form part of usual care in our centre) and quantify the variability of that change. We set out to quantify the correlation between objectively measured and self-reported PA in this patient group. Finally, as accelerometers have not previously been used in this setting, we aimed to assess how acceptable it is to use wrist-worn accelerometers to measure PA in high-risk elderly patients in the preoperative period prior to rolling them out into a larger scale programme of research.

Methods {#s2}
=======

Study approvals and population {#s2-1}
------------------------------

This study was conducted at Cambridge University Hospitals National Health Service (NHS) Foundation Trust. Written informed consent was obtained from all participants. All patients awaiting high-risk surgery are seen in a nurse-led preoperative assessment clinic (outpatient setting) as part of routine care, at which point they undergo frailty screening and may be referred to the 'perioperative review informing management of elderly patients' (PRIME) clinic (a multidisciplinary clinic specifically designed to optimise frail elderly patients preoperatively). Inclusion criteria for this study were patients referred to the PRIME clinic, participants must have had capacity to consent and complete activity questionnaires and be willing and able to wear the accelerometer around their wrist. PRIME clinic referral criteria were patients listed for major or complex surgery who were aged ≥65 years and either had a Rockwood Clinical Frailty Scale[@R14] score (CFS) of ≥4 or had a clinical picture that gave the preassessment nurse enough concern to refer for a multidisciplinary preoperative assessment. Referral to, and attendance at the PRIME clinic formed part of usual preoperative care at our institution. Participants were excluded from the study if they did not meet the inclusion criteria, they refused to participate or their PRIME clinic appointment was scheduled \<72 hours after referral for recruitment, as previous research has shown a minimum period of 72 hours of continuous accelerometer wear time is required to produce valid data.[@R13] Recruitment took place between July and December 2018.

Patient and public involvement {#s2-2}
------------------------------

Patient and public involvement (PPI) was sought during the study design process with the aim of ensuring that the research question was agreed to be important, the methods and running of the study were likely to be acceptable to patients and the documents were written appropriately for the target study population. Study documents including patient information leaflets, consent forms and information posters were circulated to Cambridge University Hospital PPI panel for review. Feedback from the PPI panel allowed us to construct more lay-friendly documents. The PPI panel considered the burden of intervention and time required to participate in research. We will consider further PPI involvement in order to disseminate the study results to those participants who requested to be informed.

Accelerometer and data collection {#s2-3}
---------------------------------

Participants wore a waterproof triaxial accelerometer (Axivity AX3, Newcastle, UK[@R15]) which has been used in other studies of functionally impaired people.[@R16] The device was worn around the wrist for 24 hours per day, for 7 days prior to their PRIME clinic visit and 7 days immediately after their PRIME clinic visit. Participants wore the device around their preferred wrist for convenience and to maximise compliance. Participants were instructed by the research team how to refit the accelerometer should they remove it for any reason. Accelerometer devices were programmed to commence data collection on the same day that the device was fitted and to record for 7 days. The accelerometer measures acceleration in three axes sampled at 100 Hz with a dynamic range of ±8* g*.

Raw accelerometery data were downloaded and visually inspected in order to detect any accelerometer technical issues, to ensure that the accelerometer was worn and recorded for the correct duration and had recorded the signals as expected. Data analyses were performed in R-package GGIR, the details of which have been previously described.[@R17]

PA-related acceleration was calculated using autocalibrated Euclidian norm minus one (ENMO).[@R18] The values presented are the average ENMO for all of the available data normalised per 24 hours cycle (diurnally balanced), with invalid data imputed using the average at similar time points on different days of the week. We chose to use ENMO as our measure of PA since previously published cut-offs for mild/moderate/vigorous intensity PA may not apply to this patient population.

The PRIME clinic visit involves a preoperative review by an anaesthetist, geriatrician, physiotherapist and occupational therapist. During this clinic visit, patients were provided with a behavioural change intervention as part of usual perioperative care at our institution (see the Behavioural change intervention section). At the PRIME clinic visit, a member of the research team retrieved the accelerometer worn by participants for the initial 7-day period and provided the participant with a new device for the second 7-day period. Participants completed two questionnaires at the PRIME clinic visit: a validated self-reported activity questionnaire; Physical Activity Scale for the Elderly (PASE),[@R19] and a locally designed acceptability questionnaire (see the Assessment of acceptability section). Participants were asked to repeat the PASE questionnaire at the end of the second 7-day wear period and return the accelerometer and completed PASE questionnaire back to the study centre in a prepaid envelope.

Assessment of acceptability {#s2-4}
---------------------------

Overall acceptability was assessed using a participant completed questionnaire using a Visual Analogue Scale from 0 to 10, 0 being 'very unacceptable' and 10 being 'very acceptable'. We also measured the length of time that the devices were worn in hours (wear-time compliance).

Behavioural change intervention (PRIME clinic visit) {#s2-5}
----------------------------------------------------

The behavioural change intervention (given as part of usual care) consisted of PA and exercise advice described as follows according to the template for intervention description and replication checklist.[@R20] The goals of the intervention were to improve PA levels on a day-to-day basis through activities of daily living (ADLs) or leisure activities, to improve specific aspects of fitness, perioperative respiratory function and promote independence with personal and domestic ADLs and leisure activities. Verbal and written advice was provided as follows: two generic exercise leaflets (general exercises for the whole body, and walking exercises), bespoke exercise programmes (generated using online Physiotools[@R21] software) and local hospital-specific respiratory exercise information leaflets were provided along with advice and information about appropriate community services. The intervention was administered by an NHS band seven physiotherapist with a background in surgery and elderly rehabilitation and an NHS band seven occupational therapist with a background in surgery, orthopaedics and elderly rehabilitation via one face-to-face session (PRIME clinic visit) lasting 40 min. The information described above was given to participants in the PRIME clinic room with the expectation that they would undertake the activities in their own homes. The intervention was tailored to each participant, depending on presentation and planned surgical procedure. Advice given to participants was decided by experienced clinicians in the PRIME clinic and was based on their clinical judgement following a comprehensive assessment. Personalised exercise programmes were designed by the physiotherapist during the clinic visit and taught to participants during this session, with a written information leaflet given to the participant to take home. Adherence to this intervention was not otherwise assessed.

Statistical analysis {#s2-6}
--------------------

We generated descriptive statistics for the number of participants, wear time in hours and average daily ENMO milligravitational units (m*g*). We analysed the difference in ENMO before and after the existing intervention using the Wilcoxon signed rank test. We also analysed ENMO stratified into orthopaedic and non-orthopaedic surgical populations.

Since accelerometery and self-reported PA (measured using PASE) are continuous variable, we analysed correlation using the Pearson correlation coefficient.

Statistical analysis was conducted using the R statistical language.[@R22] Mixed-effect models were constructed using the lme4 package[@R23]; significance testing was done using analysis of deviance. A statistical significance level of 5% was assumed throughout and no correction for multiple comparisons was made.

Results {#s3}
=======

Thirty-six patients were invited to take part in the study, of which 35 participants were recruited, 19 (54%) were women. Twenty participants (57%) were listed for orthopaedic surgery, 7 (20%) gastrointestinal surgery, 5 (14%) urological surgery and 1 each for vascular, gynaecology and breast surgery. The mean age was 79.9 years (SD=5.6 years). Characteristics of the study population are given in [table 1](#T1){ref-type="table"}. Our study was not powered to fully define the spectrum of comorbidities in this group. Instead, we summarised physical status in terms of the American Society of Anaesthesiologists physical status classification score which is widely used for perioperative risk assessment. Median nurse-assessed Rockwood CFS was 5 (IQR 4--5).

###### 

Characteristics of the study population, values are mean (SD), number (proportion)

  Characteristics of study sample (n=35)   Value
  ---------------------------------------- ------------
  Age; years                               79.9 (5.6)
  Sex                                      
   Female                                  19 (54%)
   Male                                    16 (46%)
  Rockwood Clinical Frailty Score          
   3                                       1 (2.9%)
   4                                       12 (34.3%)
   5                                       17 (48.6%)
   6                                       5 (14.3%)
  Surgical specialty                       
   Orthopaedic                             20 (57%)
   Gastrointestinal                        7 (20%)
   Urology                                 5 (14%)
   Gynaecology                             1 (3%)
   Vascular                                1 (3%)
   Breast                                  1 (3%)
  ASA score\*                              
   2                                       8 (23%)
   3                                       27 (77%)

\*ASA, American Society of Anaesthesiologists physical status classification system score.

Accelerometery data were available for analysis for 34 participants before the intervention and 30 participants after the intervention. Data from one preintervention participant were unavailable due to an accelerometer programming error, and three participants were withdrawn from the postintervention part of the study because their surgical procedure was scheduled to be \<72 hours after the PRIME clinic visit; thus, participants would not have been able to wear the device for the minimum required time of 72 hours. One participant was withdrawn from the postintervention part of the study due to skin irritation around the wrist strap (notably similar irritation was also caused by their own wristwatch), and one participant was withdrawn due to an area of bruising around the wrist strap. This participant was taking oral anticoagulants.

Preoperative baseline PA levels were obtained in 34 participants. The median baseline daily PA level was 14.3 m*g* (IQR 9.75--22.04). There was no significant difference in baseline median PA between men (12.6 m*g* (IQR 9.5--15.7)), and women (16.9 m*g* (IQR 12.5--23.9)), p=0.18). Median baseline daily PA in orthopaedic patients was 15.3 m*g* (IQR 10.1--23.5), compared with a median of 12.7 m*g* (IQR 9.2--16.6) in non-orthopaedic patients (p=0.271) as shown in [figure 1](#F1){ref-type="fig"}. Baseline PA was higher in women than men in this orthopaedic subgroup (22.84 m*g* vs 10.17 m*g*, p*=*0.046).

![Notched box plots representing physical activity (Euclidian norm minus one (ENMO), milligravitational units m*g*) before (blue) and after (red) the perioperative review informing management of elderly patients (PRIME) clinic intervention in all participants (left), participants listed for orthopaedic surgery (middle) and non-orthopaedic surgery (right). Open circle (o) represents outliers. The notch represents the 95% CI of the median; 95% CI that the medians differ if two boxes' notches do not overlap. Significant differences between 'before-', and 'after-' intervention groups are indicated with an asterisk (\*).](bmjopen-2019-032346f01){#F1}

There was a significant increase in overall daily ENMO after the standard clinical intervention (median baseline ENMO 14.3 m*g* (IQR 9.75--22.04), median ENMO postintervention 20.91 m*g* (IQR 14.83--27.53), p=0.022) as shown in [figure 1](#F1){ref-type="fig"}. There was no significant difference in ENMO before and after the intervention in patients awaiting orthopaedic surgery (median baseline ENMO 15.29 m*g* (IQR 10.07--23.5), median ENMO postintervention 20.05 m*g* (IQR 14.83--27.61), p=0.304). However, in those participants listed for non-orthopaedic surgery, there was a significant increase in mean PA following the intervention (median baseline ENMO 12.71 m*g* (IQR 9.20--16.61), median ENMO post intervention 21.49 m*g* (IQR 18.04--25.82), p=0.019); see [figure 1](#F1){ref-type="fig"}.

The distribution of PA over time for all patients is shown in [figure 2](#F2){ref-type="fig"} for both preintervention and postintervention. There was evidence for a linear increase (mixed-effect model) in PA over time in the preintervention group +0.28 m*g*/day (95% CI 0.011 to 0.53, p=0.04) with a similar finding in the postintervention group +0.15 m*g*/day (95% CI −0.19 to 0.50, p=0.37), although not achieving statistical significance. There was no evidence for a significant effect of whether the day was a weekend or not, nor was there evidence for a nonlinear time dependency.

![Physical activity (ENMO) against time before (left panel) and after (right panel) the intervention for each patient. The dots/blue lines represent the mean across the patient group with ±1 SD shaded. Only complete (2--6) days included. Mean physical activity is increased after the intervention with no discernible decline in activity over time.](bmjopen-2019-032346f02){#F2}

There was no significant difference in self-reported PASE scores before and after the PRIME clinic intervention (median PASE preintervention was 67 (IQR 31--89.75), median PASE postintervention was 65 (IQR 45.5--101) p=0.247). Furthermore, no significant statistical correlation was found between the accelerometer-measured PA and the self-reported PA measured using the PASE questionnaire, either before or after the intervention (baseline *ρ*=0.162 (p=0.4), postintervention *ρ*=−0.144 (p=0.5)).

The median wear time of the wrist-worn accelerometer was 163.2 hours (IQR 150--167.5) preintervention and 166.1 hours (IQR 162.5--167) postintervention. On average, participants wore the accelerometers for 98% of the measurement period indicating excellent wear-time compliance, with values comparable to those achieved in other studies.[@R13] Thirty-three participants completed the acceptability questionnaire, and the median overall acceptability score obtained was 10 (IQR 8--10). The high wear-time compliance, low voluntary withdrawal rate and high acceptability scores indicate overall acceptability and feasibility of measuring PA in high-risk elderly patients in the preoperative period using these accelerometers.

Discussion {#s4}
==========

These data demonstrate that wrist-worn accelerometers can successfully be used to measure PA in high-risk elderly patients in the preoperative period, and that this process was acceptable to participants. The fact that there was no statistical correlation between participant-reported PASE and accelerometer-measured PA highlights the need for more objective measures of PA[@R24] and suggests a role for such devices in perioperative research and perhaps clinical care.

We demonstrated a substantial variability in baseline PA in the frail elderly preoperative population. Our study also gives an estimate of the typical mean daily PA levels in this specific group of patients which has not previously been described. Such data should inform the planning of potential studies involving PA measurements in this setting. We found low PA levels in this population: we do not have access to a 'control' group as such a group would be difficult to define. However, by way of comparison, the UK Biobank study reported mean daily ENMO values in over three thousand 75--79 year olds (the most comparable group to ours) women of 23.9 m*g* (SD=6.5) and in men this was 22.9 m*g* (SD=6.8).[@R13] Our study population had lower baseline mean daily ENMO of 18.9 m*g* (SD=10.5) in women, and 13.71 m*g* (SD=6.1) in men, which may reflect their underlying medical conditions, frailty and increased age (mean age of our study population was 79.9 years SD 5.6).

ENMO may not be as intuitive as postprocessed PA intensity metrics such as step count or time spent in various intensities of PA. However, such metrics may not generalise outside the population in which they were developed.[@R25] Furthermore, we wanted to avoid using any potentially proprietary algorithms. Using unprocessed ENMO avoids both of these problems as it is the fundamental physical quantity measured by all accelerometers and should therefore be agnostic to patient group. Further work is be needed to develop metabolically meaningful PA intensity cut points in this patient group, but we suggest from our work that ENMO summary data are a useful surrogate even without this.

In the non-orthopaedic subgroup, we found a significant increase in PA following the PRIME clinic intervention, even though this was not optimised. Mixed-effect modelling did not show any decrease in PA over time in either the preintervention or postintervention group suggesting that PA levels were sustained at least for the duration of the measurement period. Because we had no control on which day of the week participants would be recruited from clinic, we also looked at whether activity might be different on weekend days, but this did not seem to be the case in this population. The PA levels in some patients postintervention resembled more closely the baseline levels reported in the Biobank study. The fact that PA levels increased to this extent following the unoptimised intervention is a remarkable and somewhat unexpected finding as health behavioural change is notoriously difficult to achieve.[@R10] Our findings provide some evidence to suggest that the preoperative setting may indeed represent a unique period during which behavioural interventions are more likely to result in improvements in PA, perhaps due to the well-defined endpoint (surgical procedure) and the motivation that PA may impact perioperative outcome. It seems reasonable to suggest that a well-designed complex intervention could result in greater changes in PA.

The lack of significant improvement in PA in those participants awaiting orthopaedic surgery may indicate a restriction of PA in this population, in which mobility is likely to be limited due to underlying orthopaedic problems (all orthopaedic participants were awaiting major lower limb joint replacements). The potential to increase preoperative PA in the orthopaedic population may be limited; waiting lists for joint replacement surgery in the UK are long, and such patients may have already been in the hospital system prior to the PRIME clinic visit (intervention). This potentially restricted PA, and prior engagement with hospital services may mean that these patients may have already received PA advice from their surgical and primary care teams prior to referral to the PRIME clinic and may have already reached their prehabilitation limit. Nevertheless, although PA in this subgroup group did not change following the existing unoptimised intervention, there is perhaps still scope for a better intervention, and wearable accelerometers may assist in determining what this may be. Our finding provides support for the idea that a complex intervention would need to be tailored to this population.

We asked participants to wear the accelerometers around their wrist. Traditionally, the hip has been the most widely used site for placement of the accelerometer as this was believed to best represent total body movement.[@R26] However, wear-time compliance has been a problem with hip-worn devices which limits the validity of the data analysis.[@R27] Cui *et al* [@R28] fixed an accelerometer to participants' chests using an adhesive plaster; however, one quarter of participants did not wear the device for 72 hours which may limit the validity of data. We opted for a wrist-worn device to circumvent this issue, and asked participants to wear the device continuously (day and night) for a 7-day period to simplify proceedings. We also felt that this placement would capture PA associated with ADL, likely to form a significant proportion of PA among a high-risk elderly population. While previous studies have used the non-dominant wrist,[@R13] for this pilot study we allowed a pragmatic approach to allow participants to select their preferred wrist in order to maximise compliance and total wear time. Furthermore, previous work has shown no difference in PA measurements when measured simultaneously on the dominant and non-dominant wrist.[@R29] We accept that in a frail elderly population, many of whom use walking aids, a wrist-worn device must be used with caution and further work is warranted to evaluate the transferability of data from different sites.

Limitations of this study include the small sample size. Within this small sample, we were non-selective regarding recruitment of participants from various surgical specialties. As such, we were unable to further analyse data from subgroups other than orthopaedics versus non-orthopaedics. This is an area of potential future research incorporating larger patient numbers in various subspecialties. One further limitation was that we did not attempt to relate ENMO measurements to specific ADL. This will be an important subsequent study but was outside the scope of this work as it might have reduced tolerability.

While we have demonstrated that patients' behaviour can change in the preoperative period, we do not know how this translates clinically, and indeed what degree (if any) of change in PA might lead to a change in the outcomes that are important to patients. However, it is reasonable to propose that such a relationship might exist, and further work is needed to investigate whether increasing PA levels in the preoperative period has any impact on perioperative outcome, and if so, whether the response is dose or timing dependent. Furthermore, if an association between preoperative PA and perioperative outcome is discovered, it is important to determine the minimum duration of increased PA levels required to influence patient outcome, and whether this would be feasible in the preoperative period. If optimum PA level targets can be determined, it would then be important to find out whether it is actually possible to meet PA 'targets' in the high-risk elderly population by use of preoperative interventions. Further research into the optimum prehabilitation programme for frail elderly patients in various patient cohorts is also required. While we have demonstrated that the increase in PA after the intervention was sustained throughout the 7-day measurement period, we do not know whether the increase in PA is sustained beyond this period. Further work is required to elucidate this.

Conclusion {#s5}
==========

Using wrist-worn accelerometers to characterise daily typical activity levels and assess the impact of an existing clinical intervention was feasible and acceptable in this patient population. An increase in PA levels was measured following an unoptimised routine clinical intervention, and this increase in PA was sustained for at least a week suggesting that the preoperative period may be a teachable moment in which health behavioural change interventions may be successful. Patient-reported PA did not correlate with our objective measurements. Accelerometers may therefore be a useful tool to design and validate interventions for improving PA in this setting.
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